VERA Stock: Vera Therapeutics, Inc. Stock Price, Analysis & Insights

Get live VERA stock price $32.48, comprehensive Vera Therapeutics, Inc. stock analysis, charts, news, and expert forecast. Real-time VERA stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

32.48

2.11%Today

VERA • Vera Therapeutics, Inc. • NASDAQ Global Market • Healthcare

Market Cap

2.33B

Volume

170.06K

52W High

56.05

52W Low

19.07

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Vera Therapeutics, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of treatments for significant immunological disorders, primarily within the United States. Their leading therapeutic candidate is ataci...

Contact Information

Website: https://veratx.com
Address: 8000 Marina Boulevard
Country: US

Investment Analysis & Business Insights

Healthcare

Biotechnology

Investment Highlights

✓ Strong presence in the Healthcare sector with established market position

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for Vera Therapeutics, Inc. shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Healthcare may affect company performance
⚠Past performance does not guarantee future results for Vera Therapeutics, Inc.
⚠Investors should consider how Vera Therapeutics, Inc. fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

2.33B

P/E Ratio (TTM)

-5.86

Beta

0.95

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare VERA with peer companies:

AbCellera Biologics Inc. (ABCL)

Price: $5.24
Market cap: 1.60B

Biohaven Ltd. (BHVN)

Price: $11.37
Market cap: 1.20B

Celldex Therapeutics, Inc. (CLDX)

Price: $29.86
Market cap: 1.99B

Harmony Biosciences Holdings, Inc. (HRMY)

Price: $35.61
Market cap: 2.06B

Immunome, Inc. (IMNM)

Price: $18.27
Market cap: 1.75B

Janux Therapeutics, Inc. (JANX)

Price: $13.51
Market cap: 823.90M

Nuvation Bio Inc. (NUVB)

Price: $4.75
Market cap: 1.65B

Pharvaris N.V. (PHVS)

Price: $31.67
Market cap: 2.21B

uniQure N.V. (QURE)

Price: $26.60
Market cap: 1.68B

Viridian Therapeutics, Inc. (VRDN)

Price: $15.92
Market cap: 1.43B

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.